4578
Otsuka Holdings Co.,Ltd.
大塚ホールディングス
- Industry
- Pharmaceutical
- Market
- Prime
- Accounting standards
- IFRS
- Consolidation basis
- Consolidated
Key metrics
Revenue(million JPY)
Dec 2021
1,498,276
Dec 2022
1,737,998
Dec 2023
2,018,568
Dec 2024
2,329,861
Dec 2025
2,468,892
Operating profit(million JPY)
Dec 2021
154,497
Dec 2022
150,323
Dec 2023
139,612
Dec 2024
323,564
Dec 2025
479,375
Operating profit margin(%)
Dec 2021
10.31
Dec 2022
8.65
Dec 2023
6.92
Dec 2024
13.89
Dec 2025
19.42
Profit before tax(million JPY)
Dec 2021
163,638
Dec 2022
172,954
Dec 2023
142,655
Dec 2024
335,854
Dec 2025
468,037
Profit(million JPY)
Dec 2021
125,463
Dec 2022
134,019
Dec 2023
121,616
Dec 2024
343,120
Dec 2025
363,150
Total assets(million JPY)
Dec 2021
2,820,915
Dec 2022
3,102,716
Dec 2023
3,361,244
Dec 2024
3,739,251
Dec 2025
4,197,562
Cash and cash equivalents(million JPY)
Dec 2021
410,684
Dec 2022
471,634
Dec 2023
513,341
Dec 2024
426,173
Dec 2025
534,645
Cash flows from operating activities(million JPY)
Dec 2021
228,864
Dec 2022
211,848
Dec 2023
283,232
Dec 2024
354,638
Dec 2025
403,579
Cash flows from investing activities(million JPY)
Dec 2021
-95,288
Dec 2022
-81,575
Dec 2023
-190,538
Dec 2024
-265,793
Dec 2025
-161,585
Cash flows from financing activities(million JPY)
Dec 2021
-95,844
Dec 2022
-95,474
Dec 2023
-60,260
Dec 2024
-189,367
Dec 2025
-137,344
Return on equity(%)
Dec 2021
6.5
Dec 2022
6.3
Dec 2023
5.3
Dec 2024
13.4
Dec 2025
12.6
Equity ratio(%)
Dec 2021
71.3
Dec 2022
71.7
Dec 2023
71.2
Dec 2024
73.1
Dec 2025
72.3
Earnings per share(JPY per share)
Dec 2021
231.32
Dec 2022
247.01
Dec 2023
224.1
Dec 2024
633.76
Dec 2025
685.06
Net assets per share(JPY per share)
Dec 2021
3,707.64
Dec 2022
4,101.12
Dec 2023
4,410.8
Dec 2024
5,089.58
Dec 2025
5,743.73
Dividend per share(JPY per share)
Dec 2021
100
Dec 2022
100
Dec 2023
110
Dec 2024
120
Dec 2025
140
Payout ratio(%)
Dec 2021
43.23
Dec 2022
40.48
Dec 2023
49.09
Dec 2024
18.93
Dec 2025
20.44
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.